The Global Bioabsorbable Scaffolds Market was valued at USD 450 Million in 2023 and is projected to reach USD 1,200 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 21.7% during the forecast period (2023–2028). This growth is being driven by rising incidences of cardiovascular diseases, advancements in minimally invasive procedures, and the increasing demand for regenerative therapies in hospitals and research institutes worldwide.

As the medical device sector shifts toward innovative, patient-centric solutions that promote natural healing and reduce long-term complications, attention turns to the pioneering companies developing bioabsorbable scaffolds. These temporary structures support tissue regeneration before safely degrading in the body. In this blog, we profile the Top 10 Companies in the Bioabsorbable Scaffolds Industry—a blend of established medtech firms, specialized biotech innovators, and research-driven entities shaping the future of vascular, nerve, and corneal tissue engineering.

---

🔟 1. Abbott Vascular

Headquarters: Santa Clara, California, USA
Key Offering: Bioresorbable Vascular Scaffolds (BVS), Biodegradable Vascular Scaffold Material

Abbott Vascular stands as a global leader in cardiovascular interventions, with its pioneering work in bioabsorbable scaffolds revolutionizing coronary artery treatments. The company’s Absorb BVS, though facing challenges in earlier iterations, has paved the way for next-generation devices that dissolve over time, restoring vessel function without permanent implants. Abbott’s focus spans clinical applications in hospitals, supporting procedures that address stenosis and improve patient recovery rates.

Innovation Initiatives:

• Ongoing R&D in polymer-based scaffolds for enhanced radial strength
• Collaborations with regulatory bodies for advanced clinical trials
• Commitment to personalized medicine through scaffold customization

Download FREE Sample Report: 2023-2028 Global and Regional Bioabsorbable Scaffolds Industry Status and Prospects Professional Market – View in Detailed Research Report

---

9️⃣ 2. Biotronik

Headquarters: Bülach, Switzerland
Key Offering: Absorbable Metal Scaffolds, Biodegradable Vascular Scaffold Material

Biotronik excels in developing bioabsorbable technologies for vascular applications, offering scaffolds that degrade predictably to minimize thrombosis risks. Operating across Europe and North America, the company supplies innovative devices to hospitals and research centers, emphasizing biocompatibility and long-term vessel patency. Their portfolio addresses the evolving needs of interventional cardiology, where temporary support is crucial for healing.

Innovation Initiatives:

• Investment in magnesium-based scaffolds for faster resorption
• Partnerships with clinical investigators for real-world evidence collection

---

8️⃣ 3. REVA Medical, Inc

Headquarters: San Diego, California, USA
Key Offering: Fantom Scaffolds, Tyrosine-Derived Bioresorbable Scaffolds

REVA Medical specializes in polymer scaffolds designed for coronary applications, with their Fantom platform featuring ultra-high strength and full resorption within three years. This approach supports natural arterial motion post-implantation, making it ideal for younger patients. The company’s devices are integrated into hospital protocols globally, driving adoption in high-risk procedures.

Innovation Initiatives:

• Advanced polymer engineering for improved deliverability
• Clinical studies demonstrating reduced reintervention rates

---

7️⃣ 4. Microport Scientific Corporation

Headquarters: Shanghai, China
Key Offering: Firehawk Bioresorbable Scaffolds, Biodegradable Vascular Materials

Microport leads in Asia-Pacific markets with its hybrid bioresorbable platforms that combine drug-eluting technology with scaffold degradation. Serving hospitals and research institutes, the company focuses on cost-effective solutions for emerging economies, where cardiovascular burdens are rising. Their innovations bridge traditional stents and fully absorbable options, enhancing accessibility.

Innovation Initiatives:

• Expansion of scaffold applications to peripheral arteries
• Asia-centric clinical trials for diverse patient populations

Download FREE Sample Report: 2023-2028 Global and Regional Bioabsorbable Scaffolds Industry Status and Prospects Professional Market – View in Detailed Research Report

---

6️⃣ 5. OrbusNeich

Headquarters: Fort Lauderdale, Florida, USA
Key Offering: Combo Dual-Therapy Scaffolds, Bioresorbable Components

OrbusNeich integrates bioabsorbable elements into its drug-eluting stent systems, promoting endothelialization while gradually disappearing. With a strong presence in North America and Europe, the company supplies scaffolds for complex lesions in hospital settings. Their technology reduces inflammation, offering better outcomes in diabetic patients and those with multivessel disease.

Innovation Initiatives:

• Hybrid designs for transitional market adoption
• Focus on sirolimus-eluting bioresorbable platforms

---

5️⃣ 6. Kyoto Medical Planning Co., Ltd

Headquarters: Kyoto, Japan
Key Offering: Magmaris Bioresorbable Scaffolds, Magnesium Alloys

Kyoto Medical Planning pioneers magnesium-based scaffolds that resorb faster than polymers, ideal for small vessel treatments. Operating primarily in East Asia, their products support research into acute coronary syndromes. The scaffolds’ radiopacity aids precise deployment, making them a preferred choice in high-volume cath labs.

Innovation Initiatives:

• Current production capacity supporting regional trials
• Target expansion to 50% market share in Japan by 2028

---

4️⃣ 7. Elixir Medical

Headquarters: Milpitas, California, USA
Key Offering: DynamX Bioabsorbable Scaffolds, Adaptive Platforms

Elixir Medical develops dynamic scaffolds that unlock after resorption, allowing natural vessel pulsation. This innovation addresses limitations of rigid implants, with applications in hospitals for stable angina treatments. Their pipeline emphasizes long-term durability, positioning them as a disruptor in Western markets.

Innovation Initiatives:

• Mechanistic studies on vessel motion restoration
• Global partnerships for pediatric cardiology extensions

---

3️⃣ 8. ICON Interventional Systems

Headquarters: Hercules, California, USA
Key Offering: Magmaris-Integrated Scaffolds, Degradable Nerve Tissue Variants

ICON Interventional Systems focuses on next-gen magnesium scaffolds for both vascular and emerging nerve applications. With a footprint in North America, they collaborate with research institutes to explore beyond cardiology, such as peripheral nerve repair. Their scaffolds offer controlled degradation, enhancing regenerative potential.

Innovation Initiatives:

• Diversification into nerve tissue engineering
• Pre-clinical data on reduced scaffold thrombosis

---

2️⃣ 9. Sinomed

Headquarters: Tianjin, China
Key Offering: BuMA Supreme Bioresorbable Scaffolds, Polymer-Based Materials

Sinomed advances affordable bioabsorbable options for South Asian and African markets, with scaffolds tailored for high-prevalence coronary conditions. Their hospital-supplied devices emphasize safety and efficacy, supported by local manufacturing to lower costs. This strategy fosters wider adoption in resource-limited settings.

Innovation Initiatives:

• Cost-optimization for emerging economies
• Integrations with telemedicine for post-procedure monitoring

---

1️⃣ 10. Arterial Remodeling Technologies

Headquarters: Noisy-le-Grand, France
Key Offering: ART Scaffolds, Zero-Strut Bioresorbable Designs

Arterial Remodeling Technologies innovates with minimal material scaffolds that promote rapid healing. Based in Europe, they target research institutes and hospitals for acute myocardial infarction cases. Their unique architecture reduces malapposition risks, advancing the field toward fully transient implants.

Innovation Initiatives:

• End-to-end solutions for STEMI procedures
• Strategic alliances with EU research consortia

Get Full Report Here: 2023-2028 Global and Regional Bioabsorbable Scaffolds Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Bioabsorbable Scaffolds Is Regenerative and Advanced

The bioabsorbable scaffolds market is experiencing transformative growth. While challenges like resorption rates persist, the sector is channeling significant investments into biomaterial advancements, clinical validations, and expanded applications beyond vascular uses to nerve and corneal tissues.

📈 Key Trends Shaping the Market:

• Accelerated R&D in hybrid polymer-metal scaffolds across North America, Europe, and Asia
• Regulatory approvals pushing for 20-30% market penetration by 2028
• Integration of AI in scaffold design and patient-specific modeling
• Collaborations between medtech firms and biotech for multi-application platforms

Get Full Report Here: 2023-2028 Global and Regional Bioabsorbable Scaffolds Industry Status and Prospects Professional Market – View in Detailed Research Report

The companies profiled here are not only supporting tissue regeneration—they’re leading the paradigm shift toward temporary, healing-focused medical devices that promise better long-term health outcomes.

Download FREE Sample Report: 2023-2028 Global and Regional Bioabsorbable Scaffolds Industry Status and Prospects Professional Market – View in Detailed Research Report